
Isoliquiritigenin
CAS No. 961-29-5
Isoliquiritigenin( GU 17 | ILQ | ISL )
Catalog No. M16863 CAS No. 961-29-5
Isoliquiritigenin, an anti-tumor flavonoid from the root of Glycyrrhiza glabra, inhibits aldose reductase with an IC50 of 320 nM.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 29 | In Stock |
![]() ![]() |
10MG | 37 | In Stock |
![]() ![]() |
25MG | 49 | In Stock |
![]() ![]() |
50MG | 69 | In Stock |
![]() ![]() |
100MG | Get Quote | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameIsoliquiritigenin
-
NoteResearch use only, not for human use.
-
Brief DescriptionIsoliquiritigenin, an anti-tumor flavonoid from the root of Glycyrrhiza glabra, inhibits aldose reductase with an IC50 of 320 nM.
-
DescriptionIsoliquiritigenin, an anti-tumor flavonoid from the root of Glycyrrhiza glabra, inhibits aldose reductase with an IC50 of 320 nM.
-
In Vitro——
-
In Vivo——
-
SynonymsGU 17 | ILQ | ISL
-
PathwayEndocrinology/Hormones
-
TargetReductase
-
RecptorAldose reductase
-
Research AreaOther Indications
-
Indication——
Chemical Information
-
CAS Number961-29-5
-
Formula Weight256.25
-
Molecular FormulaC15H12O4
-
Purity>98% (HPLC)
-
SolubilityEthanol: 51 mg/mL (199.02 mM); DMSO: 51 mg/mL (199.02 mM)
-
SMILESO=C(C1=CC=C(O)C=C1O)/C=C/C2=CC=C(O)C=C2
-
Chemical Name(E)-1-(2,4-dihydroxyphenyl)-3-(4-hydroxyphenyl)prop-2-en-1-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference



-
Lidorestat
Lidorestat (IDD-676) is an aldose reductase inhibitor (IC50: 5 nM) with effective, selective and oral activity. Lidorestat improves nerve conduction and reduces the formation of cataracts.
-
BYAKANGELICIN(b)
BYAKANGELICINa main furanocoumarin constituent isolated and characterized as an aldose reductase inhibitorand is effective for the treatment of sugar cataracts and diabetic neuropathy and hence might be useful as a lead compound for the development of new type drugs for clinical use.
-
Ganoderic acid C2
Ganoderic acid C2 has anti-inflammatory,and anti-tumor-promoting activities. Ganoderic acid C2 can inhibit histamine release, it also has inhibitory effects on the induction of Epstein-Barr Virus early antigen.